Report : North America Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits, Chemicals and Reagents, and Consumables), Indication (Infectious Diseases, Endocrine Diseases, Oncology, Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, and Others), and End User (Diagnostic Laboratories, Hospitals, Biopharmaceutical Companies, and Academic and Research Institutes)

Kits Segment has the Largest Market Share of North America Antibody Testing Market during 2021–2028

According to our latest study on “North America Antibody Testing Market Forecast to 2028 –Analysis – by Products, Indication, and End User” The North America antibody testing market is expected to grow from US$ 3,308.90 million in 2021 to US$ 5,185.67 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the market is driven with the burden of chronic diseases is expected to drive the North America antibody testing market. However, limitations of antibody screening tests hinder the growth of the North America antibody testing market.  

The North America antibody testing market is segmented into products, indication, and end User. Based on product, the market has been categorized as kits, chemicals and reagents, and consumables. The kits segment accounted for the largest market share in 2020. Based on indication, the North America antibody testing market is segmented into infectious diseases, endocrine diseases, oncology, pregnancy, cardiovascular diseases, autoimmune diseases, and others.  In 2020, the infectious diseases segment accounted for the largest market share. Based on end user, the North America antibody testing market is segmented into diagnostic laboratories, hospitals, biopharmaceutical companies, and academic and research institutes. In 2020, the diagnostic laboratories accounted for the largest market share. Based on country, the North America antibody testing market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2020.

Abbott, Abcam plc, Agilent Technologies, Inc., BD, BIO-RAD LABORATORIES INC., DiaSorin S.p.A., F. HOFFMANN-LA ROCHE LTD., THERMO FISHER SCIENTIFIC INC., Trinity Biotech, ZEUS Scientific are among the leading companies in the North America antibody testing market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com 

Download Free PDF Brochure